Controlling the bacterial cell cycle

In the 15 December Science, Laub et al. find that a full 19% of the genome of the bacterium Caulobacter crescentus is subject to cell-cycle-specific regulation (Science 2000, 290:2144-2148). A surprising number of genes are induced, as in yeast, just before they are needed. Other genes, such as those directing the construction of the flagella and pilus, are induced in transcriptional cascades, with the order of induction reflecting the order of assembly of the respective apparatus. Laub et al. a

Written byWilliam Wells
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

In the 15 December Science, Laub et al. find that a full 19% of the genome of the bacterium Caulobacter crescentus is subject to cell-cycle-specific regulation (Science 2000, 290:2144-2148). A surprising number of genes are induced, as in yeast, just before they are needed. Other genes, such as those directing the construction of the flagella and pilus, are induced in transcriptional cascades, with the order of induction reflecting the order of assembly of the respective apparatus. Laub et al. also use their microarray to determine the effect of decreasing or increasing the function of the CtrA response regulator. Temporal and spatial regulation of CtrA are vital for the differentiation and cell cycle progression of Caulobacter cells, and Laub et al. find that 26% (144 of 553) of all cell-cycle-dependent transcripts are directly or indirectly affected by CtrA levels. Candidates for the other important cell cycle regulators in Caulobacter include 27 ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies